Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4CCD

STRUCTURE OF MOUSE GALACTOCEREBROSIDASE WITH D-GALACTAL: ENZYME- INTERMEDIATE COMPLEX

Summary for 4CCD
Entry DOI10.2210/pdb4ccd/pdb
Related4CCC 4CCE
DescriptorGALACTOCEREBROSIDASE, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-deoxy-alpha-D-galactopyranose, ... (6 entities in total)
Functional Keywordshydrolase, krabbe disease, glycosyl hydrolase, galactosidase, d-galactal, lysosomal storage disease, enzyme-intermediate complex
Biological sourceMUS MUSCULUS (HOUSE MOUSE)
Cellular locationLysosome (By similarity): P54818
Total number of polymer chains1
Total formula weight76295.39
Authors
Hill, C.H.,Graham, S.C.,Read, R.J.,Deane, J.E. (deposition date: 2013-10-21, release date: 2013-12-11, Last modification date: 2024-11-06)
Primary citationHill, C.H.,Graham, S.C.,Read, R.J.,Deane, J.E.
Structural Snapshots Illustrate the Catalytic Cycle of Beta-Galactocerebrosidase, the Defective Enzyme in Krabbe Disease
Proc.Natl.Acad.Sci.USA, 110:20479-, 2013
Cited by
PubMed Abstract: Glycosphingolipids are ubiquitous components of mammalian cell membranes, and defects in their catabolism by lysosomal enzymes cause a diverse array of diseases. Deficiencies in the enzyme β-galactocerebrosidase (GALC) cause Krabbe disease, a devastating genetic disorder characterized by widespread demyelination and rapid, fatal neurodegeneration. Here, we present a series of high-resolution crystal structures that illustrate key steps in the catalytic cycle of GALC. We have captured a snapshot of the short-lived enzyme-substrate complex illustrating how wild-type GALC binds a bona fide substrate. We have extensively characterized the enzyme kinetics of GALC with this substrate and shown that the enzyme is active in crystallo by determining the structure of the enzyme-product complex following extended soaking of the crystals with this same substrate. We have also determined the structure of a covalent intermediate that, together with the enzyme-substrate and enzyme-product complexes, reveals conformational changes accompanying the catalytic steps and provides key mechanistic insights, laying the foundation for future design of pharmacological chaperones.
PubMed: 24297913
DOI: 10.1073/PNAS.1311990110
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.97 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon